Adjuvant Chemotherapy for Patients with Breast Cancer Based on Clinical and Evolving Oncotype DX Criteria

Faculty Medicine Year: 2020
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Breast Care Karger Volume:
Keywords : Adjuvant Chemotherapy , Patients with Breast Cancer    
Abstract:
-Oncotype DX assay recurrence score (ODX-RS) cut-off values have recently changed after the publication of the TAILOR-X trial results. We aim to explore decisions for adjuvant chemotherapy (ACT) based on physicians’ clinical assessment and the evolving ODX-RS. -Overtreatment and discrepancies in the management of patients with ER+/Her2–/LN– early BC can be minimized by the implementation of ODX genomic assay. Some differences in ACT recommendations exist between ODX-RS-1 and ODX-RS-2.
    
     
 
       

Author Related Publications

    Department Related Publications

    • Foad Mohamed Mohamed Abotaleb, "الاحتفاظ بالمثانة البولية فى سرطان الخلايا الانتقالية التوسعى عن طريق الاستئصال الجزئى عبر قناة مجرى البول والعلاج الكيميائى سى . أم . ف", لايوجد, 1900 More
    • Foad Mohamed Mohamed Abotaleb, "المضاعفات الكبدية التى تحدث بعد عملية زرع النخاع العظمى الذاتى لمرضى سرطان الغدد الليمفاوية الذين يحملون الاجسام المضادة لفيروس الالتهاب الكبدى الوبائى من النوع سى", لايوجد, 1900 More
    • Shereen Mostafa Saleh Elshorbagy, "- Detection of Paroxysmal Hemogloinuria Clones In patients With Pancytopenia", . IJAR 3,12,866-875; 2015, 2015 More
    • Shereen Mostafa Saleh Elshorbagy, "- CD19 and CD56 Antigens Expression in Acute Myeloid Leukemia Identifies Patients with Prognosis in Egypt Adverse", . IJSR 5; 2016, 2016 More
    • Ahmed Abdelrehem Ahmed Abdulrihem, "Significance of PAX (CDX2) gene expression in adult acute Myeloid leukemia", http://www.journalijar.com/, 2015 More
    Tweet